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Introduction: Legionnaires’ disease is an acute pneumonia caused by inhalation or aspiration of aerosols
contaminated with Legionella bacteria. The majority (>90%) of Legionnaires’ disease cases are caused by the species
Legionella pneumophila, and about 85% more specifically by L. pneumophila serogroup 1 that can be detected
by a fast and easy to perform urinary antigen test. Previously reported sources of infection include cooling towers,
plumbing systems of hospitals, and whirlpool spas, but for the majority of cases of Legionnaires’ disease the source
of infection remains unknown.
Case presentation: A 52-year-old Caucasian man was admitted to a Dutch hospital with pneumonia, where a culture
of the available bronchial lavage was found positive for L. pneumophila serogroup 3, confirming the diagnosis of
Legionnaires’ disease. An environmental investigation identified a manually operated pressure test pump at the metal
processing company where he worked as the source of infection: the water sample from the pump contained 9·8×103
colony forming units/L L. pneumophila, and sequence-based typing showed the same sequence type (ST93) for both
the clinical and environmental strains.
Conclusion: This case shows that Legionnaires’ disease can be acquired by exposure to relatively rare sources that are
not considered in regular control and prevention measures.
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Legionnaires’ disease (LD) is an acute pneumonia caused
by Legionella species, with the major route of transmission
being inhalation of the bacterium that is disseminated into
the air as an aerosol from either natural or human-made
sources [1]. It was named after a point-source outbreak in
a hotel that hosted the convention of the American Legion
in 1976 [2,3]. The disease is characterized by an acute
pneumonia, a low attack rate (0.1 to 5%) and an average
incubation time of 2 to 10 days, although it may even
exceed this period [1-4]. LD is thought to account for 2
to 15% of all community-acquired pneumonias, and
proves fatal in about 6% of cases [1,5-7]. The majority
(>90%) of LD cases are caused by the species Legionella
pneumophila, and about 85% more specifically by L.
pneumophila serogroup 1 [8,9].* Correspondence: s.euser@streeklabhaarlem.nl
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In February, 2012, a 52-year-old Caucasian man with no
underlying disease (but a cigarette smoker) was admitted
to the intensive care unit of a Dutch hospital, with high
fever, shortness of breath, electrolyte imbalance, diarrhea,
and neurological symptoms. Chest radiography showed
areas of consolidation in both his lungs and confirmed
the diagnosis of pneumonia. He was treated with intra-
venous ciprofloxacin (400mg daily), intravenous cefuroxime
(6 days, 1000mg every 8 hours), and doxycycline oral
(3 days, 200mg twice daily). Following negative results
for both a L. pneumophila urinary antigen test, and a
polymerase chain reaction (PCR) assay that targeted
the 5S ribosomal deoxyribonucleic acid (DNA) gene
performed on a sputum sample (DNA extraction by
NucliSENS® easyMAG®, bioMérieux, Durham, USA),
treatment with intravenous ciprofloxacin was stopped
after 4 days [10]. Two days later, both PCR and culture
of a bronchial lavage sample were found positive for
L. pneumophila (serogroup 3), and the treatment with
intravenous ciprofloxacin was continued for anothertd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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13 days, recovered and left the hospital after 23 days.
In accordance with the National Legionella Outbreak
Detection Programme that was installed in the Netherlands
in 2002, an investigation was performed to find the source
of infection [11]. During the source investigation, two
potential sources were identified: (1) the house of the
patient where he had used taps and shower, and (2) the
metal processing company where he worked and was
exposed to water-based cutting fluids, and a pressure
test pump (Figure 1) that uses water to evaluate the
quality of the produced industrial iron molds. With this
manually operated pressure test pump, molds are tested
for leakages by pushing water through the mold with
increasing air pressure. When a leak is present, respirable
water aerosols are sprayed around by the pump, and the
pressure drops. Samples were taken from the patient’s
home (taps and shower), from the cutting-fluids and water
reservoir of the pump at the company. All nine samples
from his home were negative, but one of the five samples
from the company was positive for L. pneumophila. The
sample from the water reservoir of the pressure test
pump contained 9·8×103 colony forming units/L. Both
L. pneumophila serogroup 1 and serogroup 3 were isolated
from this sample. Sequence-based typing (SBT) showed
the same sequence type (ST93) for both the clinical
and environmental L. pneumophila serogroup 3 strains
[12]. This sequence type was previously reported for only
29 clinical and 15 environmental isolates according to
the European Working Group for Legionella Infections
SBT database which contains sequence types of over
6600 L. pneumophila strains [13]. The high pressure pump
was dismantled and thoroughly cleaned and rinsed several
times, and control measures and changes in the working
procedure were implemented. Employees are now required
to wear filtering facepiece 2 respirator masks when
operating the pump and the water reservoir is emptiedFigure 1 Pressure test pump.and dried after every use. No other cases of LD related to
this company were reported among the other employees.
Conclusions
The majority of LD cases (approximately 79%) are caused
by L. pneumophila serogroup 1, although this may well
be influenced by the common use of diagnostic tests
(urinary antigen tests) that are sensitive for L. pneumophila
serogroup 1, but have difficulties in detecting other
serogroups [1]. The case reported here demonstrates
the importance of using additional diagnostic methods
(culture), besides the fast and easy to perform urinary
antigen tests, to obtain a more accurate diagnosis. Fur-
thermore, this case shows that LD can be acquired by
exposure to relatively rare (not previously reported)
sources that are not considered in regular control and
prevention measures that are applied to well-known
potential sources of LD like cooling towers and the
plumbing systems of hospitals.
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